Waypoint Wealth Counsel Ironwood Pharmaceuticals Inc Transaction History
Waypoint Wealth Counsel
- $253 Billion
- Q3 2025
A detailed history of Waypoint Wealth Counsel transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Waypoint Wealth Counsel holds 12,658 shares of IRWD stock, worth $24,303. This represents 0.01% of its overall portfolio holdings.
Number of Shares
12,658Holding current value
$24,303% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding IRWD
# of Institutions
181Shares Held
159MCall Options Held
11.2MPut Options Held
0-
Black Rock Inc. New York, NY22.9MShares$43.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.2MShares$31.1 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY16.2MShares$31 Million0.2% of portfolio
-
Sarissa Capital Management LP Greenwich, CT15.9MShares$30.6 Million8.54% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny8.41MShares$16.1 Million0.01% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $294M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...